Retreating chronic hepatitis C with dail
โ
Bruce R. Bacon; Mitchell L. Shiffman; Flavia Mendes; Reem Ghalib; Tarek Hassanei
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 244 KB
๐ 1 views
Up to 50% of patients with chronic hepatitis C fail to respond to initial therapy with pegylated interferon (PEG-IFN) and ribavirin (RBV). With unsuccessful viral eradication, these patients remain at risk for developing progression of their liver disease. Retreatment with PEG-IFN/RBV yields sustain